| Dr Michael Joseph Pankratz, MD | |
|
3135 Middle Road, Columbus, IN 47203-4472 | |
| (812) 373-7777 | |
| (812) 373-0772 |
| Full Name | Dr Michael Joseph Pankratz |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 3135 Middle Road, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043265093 | NPI | - | NPPES |
| 200281200A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01051787A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pankratz Medical Llc | 3870864283 | 2 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.
Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 4 days ago
| Entity Name | Pankratz Eye Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871530642 PECOS PAC ID: 0840226148 Enrollment ID: O20050916000137 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.
Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 4 days ago
| Entity Name | Pankratz Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588192157 PECOS PAC ID: 3870864283 Enrollment ID: O20170803001500 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.
Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Joseph Pankratz, MD 3135 Middle Road, Columbus, IN 47203-4472 Ph: (812) 373-7777 | Dr Michael Joseph Pankratz, MD 3135 Middle Road, Columbus, IN 47203-4472 Ph: (812) 373-7777 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration ("SFDA") to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant used in the prevention and treatment of Influenza A and Influenza B. Zanamivir is marketed globally by GlaxoSmithKline under the trade name Relenza.
Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Profil Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, jointly announced today a strategic alliance to offer Profil Institute customers use of Rosa's modeling technology to simulate disease physiology, drug action, patient variability, and trial outcomes for their early phase clinical development programs.
› Verified 4 days ago
Dr. Stephen G Brueggemann, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6051 Channel Dr, Columbus, IN 47201 Phone: 812-342-0343 | |
Max Alan Henry, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1930 Doctors Park Dr, Columbus, IN 47203 Phone: 812-372-4463 Fax: 812-372-2802 | |
Douglas R Wilson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3902 25th St, Columbus, IN 47203 Phone: 812-375-9390 |